home       Kontakt       Disclaimer

Praxis | Labor    Aeschenvorstadt 57    CH-4053 Basel

Endokrinologie
Diabetologie
Osteologie

Praxis

Labor

Patienten

Publikationen

Forschung

Aktuelles

Titel Bild: 2010

Publikationen

2018        2017        2016        2015        2014        2013        2012        2011        2010        2009        2008

Bischof M., Kraenzlin M., Bucher H., Sendi P.
Cost-Effectiveness of Risedronate Treatment for Preventing Osteoporotic Fractures in Swiss Postmenopausal Women.

Open Pharmaco-econom.&Health Econom. J. (2010), 2:25-33

Bodmer M., Meier C., Krähenbühl S., Jick S.S., Meier C.R.
Long-term metformin use is associated with decreased risk of breast cancer

Diabetes Care (2010), 33: 1304-1308

Bodmer M., Meier C., Kraenzlin M.E., Meier C.R
Proton pump inhibitors and fracture risk: True Effect or Residual Confounding?

Drug Safety (2010), 33: 843-852

Christ E., Giusti V., Meier C., Meier C.A., Pralong F.
Hormonal and nutritional treatments in anti-ageing medicine:
A position statement from the Swiss Society for Endocrinology and Diabetes

Schweiz Med Forum (2010), 10: 271

Cremers S., Meier C., Seibel M.J.
Markers of bone remodelling and the aging skeleton.

In: Orwoll E., Bilezikian J., Vanderschueren D (eds), Osteoporosis in men, 2nd ed. Academic Press, San Diego (2010), 423-434

Dürsteler K, Kowalewski R, Bloch N, Wiesbeck G, Kraenzlin M, Stohler R.
Patients on injectable diacetylmorphine maintenance have low bone mass.

Drug Alcohol Rev 2010; publ. online

Keel C., Kraenzlin C.A., Müller B., Kraenzlin M.E., Meier C.
Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice

J Bone Miner Metab (2010), 28: 68-76

Kraenzlin M.E., Graf C., Meier C., Kraenzlin C.A., Friederich N.F.
Beneficial effect of bisphosphonates in osteonecrosis of the knee

Knee Surg Sports Traumatol Arthrosc (2010), 18: 1638-1644

Kraenzlin M.E., Meier C.
Diabetes mellitus und Osteoporose

D-Journal (2010), 203: 6-11

Kraenzlin M.E., Meier C.
Osteoporose: Wann lohnt sich eine Knochendichte-Messung wirklich?

Hausarzt Praxis (2010), 4: 10-13

Kraenzlin M.E., Meier C.
Diagnostic fortuit - traitment indispensable?

CME pour le médecin de premiers recours (2010), 5: 9-12

Kraenzlin M.
Frakturrisiko und therapeutische Intervention

Journal für Mineralstoffwechsel (2010), 17 (Suppl 1): 39-41

Maggio AB, Ferrari S, Kraenzlin M, Marchand LM, Schwitzgebel V, Beghetti M et al.
Decreased bone turnover in children and adolescents with well controlled type 1 diabetes.

J Pediatr Endocrinol Metab 2010; 23(7):697-707

Meier C., Brauchli Y.B., Jick S.S., Kraenzlin M.E., Meier C.R.
Use of depot medroxyprogesterone acetate and fracture risk

J Clin Endocrinol Metab (2010), 95: 4909-4916

Meier C., Seibel M.J., Kraenzlin M.E.
Biochemical markers of bone turnover: Clinical aspects

In: Osteoporosis: Pathophysiology and Clinical Management, 2nd ed. Ed: Adler R.A. (2010), 131-155

Meier C., Seibel M.J., Handelsman D.J.
Testicular dysfunction and bone. In: Orwoll E., Bilezikian J., Vanderschueren D (eds), Osteoporosis in men, 2nd ed. Academic Press, San Diego (2010), 179-184

Meier C. , Kraenzlin M.E.
Krafttraining und Knochengesundheit im Alter

In: Kräftig altern – Die Bedeutung der Kraft im demographischen Wandel. Ed: Menzi et al. (2010), 47-56

Meier C.
Hormonale Ablationstherapie bei Mann und Frau : Folgen für den Knochen

Journal für Mineralstoffwechsel (2010), 17 (Suppl 1): 21-24

Meier C., Kraenzlin M.E.
Primärer Hyperparathyroidismus: Zufällig bemerkt, zwangsläufig zu behandeln?

Hausarzt Praxis (2010), 9: 7-10

Meier C., Kraenzlin M.E.
Hyperparathyroidie primaire

CME pour le médecin de premiers recours (2010), 5: 9-12

Meyer U, Romann M, Zahner L, Schindler C, Puder JJ, Kraenzlin M et al.
Effect of a general school-based physical activity intervention on bone mineral content and density:
A cluster-randomized controlled trial.

Bone (2010), epub

Rizzoli R., Amman P., Birkhäuser M., Ferrari S., Häuselmann H.J., Kraenzlin M.E., Krieg M.A., Lippuner K., Meier C., Theiler R., Uebelhart D., Wimpfheimer C.
Osteoporose: Von der osteodensitometrischen Diagnose zur Evaluation des absoluten Frakturrisikos

Swiss Med Forum (2010), 10 : 111-113

Seibel M.J., Meier C.
Biochemical markers of bone turnover: Basic biochemistry and variability

In: Osteoporosis: Pathophysiology and Clinical Management, 2nd ed. Ed: Adler R.A. (2010), 97-130

Walter M.A., Meier C., Radimerski T., Kranezlin M.E., Müller-Brand J., deGroot J.W.B., Kema I.P., Müller B.
Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer

Cancer (2010), 116: 31-40

© endonet 2018      gestaltung sabinastucky.ch